Impact of thalidomide therapy on hemoglobin and red blood cell indices
The effect of thalidomide on Hb level over 30 months of therapy showed that the Hb level significantly increased from a mean level of 6 g/dL at baseline to 7.4 g/dL at 6th month (p ≤ 0.001) and 8 g/dL at 30th month (p ≤ 0.001) of the treatment (Fig. Change in hemoglobin and RBC indices at different time intervals. 